/
Navigation
Chronicles
Browse all articles
Explore
Semantic exploration
Research
Entity momentum
Nexus
Correlations & relationships
Story Arc
Topic evolution
Drift Map
Semantic trajectory animation
Posts
Analysis & commentary
Pulse API
Tech news intelligence API
Browse
Entities
Companies, people, products, technologies
Domains
Browse by publication source
Handles
Browse by social media handle
Detection
Concept Search
Semantic similarity search
High Impact Stories
Top coverage by position
Sentiment Analysis
Positive/negative coverage
Anomaly Detection
Unusual coverage patterns
Analysis
Rivalry Report
Compare two entities head-to-head
Semantic Pivots
Narrative discontinuities
Crisis Response
Event recovery patterns
Connected
Search: /
Command: ⌘K
Embeddings: large
TEXXR ▲
TEXXR

Chronicles

The story behind the story

← → days · ↑ ↓ browse · Enter similar · o open

Atomwise, which develops a machine learning-based drug discovery service, raises $123M Series B led by B Capital and Sanabil Investments

With a slew of partnerships with large pharmaceutical companies under its belt and the successful spin out of at least one new company …

TechCrunch Jonathan Shieber

Related Coverage

Discussion

  • @mattocko Matt Ocko on x
    Better medicines, faster, at lower cost, for more people - @DCVC co @AtomwiseInc delivers this today, w/ $123M in new funding, $5.5B of deals, a credible early pipeline larger than multiple big pharmas put together, & an AI & data advantage years ahead https://techcrunch.com/...